The study successfully demonstrates that the fusion of deep learning with Radiomics analysis significantly improves the prediction accuracy of HER-2 status, offering a new strategy for personalized breast cancer treatment and prognostic assessments. Here, ERBB2 is linked to breast carcinoma.